Total Payments
$6,418
2024 Payments
$467.82
Companies
42
Transactions
419
Medicare Patients
2,772
Medicare Billing
$209,509
Payment Breakdown by Category
Food & Beverage$6,365 (99.2%)
Education$53.45 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,365 | 418 | 99.2% |
| Education | $53.45 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,052 | 43 | $0 (2020) |
| ABBVIE INC. | $816.40 | 49 | $0 (2024) |
| Novo Nordisk Inc | $726.01 | 46 | $0 (2024) |
| PFIZER INC. | $542.97 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $514.33 | 32 | $0 (2022) |
| Amgen Inc. | $480.33 | 37 | $0 (2024) |
| Astellas Pharma US Inc | $223.29 | 12 | $0 (2023) |
| Abbott Laboratories | $222.48 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $207.99 | 17 | $0 (2023) |
| GlaxoSmithKline, LLC. | $196.14 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $467.82 | 23 | ABBVIE INC. ($151.07) |
| 2023 | $722.22 | 43 | ABBVIE INC. ($288.13) |
| 2022 | $389.14 | 23 | Abbott Laboratories ($83.12) |
| 2021 | $519.46 | 38 | AbbVie Inc. ($261.14) |
| 2020 | $788.66 | 48 | AstraZeneca Pharmaceuticals LP ($260.46) |
| 2019 | $1,324 | 91 | AstraZeneca Pharmaceuticals LP ($329.53) |
| 2018 | $1,327 | 90 | AstraZeneca Pharmaceuticals LP ($270.80) |
| 2017 | $879.60 | 63 | Boehringer Ingelheim Pharmaceuticals, Inc. ($198.34) |
All Payment Transactions
419 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Diabetes Care | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Inflammation | ||||||
| 08/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: VACCINES | ||||||
| 07/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Diabetes Care | ||||||
| 03/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Diabetes Care | ||||||
| 02/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Diabetes Care | ||||||
| 01/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Diabetes | ||||||
| 01/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 643 | 963 | $146,429 | $45,273 |
| 2022 | 17 | 803 | 1,127 | $180,734 | $45,665 |
| 2021 | 19 | 755 | 1,110 | $163,165 | $66,153 |
| 2020 | 11 | 571 | 880 | $142,479 | $52,418 |
Total Patients
2,772
Total Services
4,080
Medicare Billing
$209,509
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 456 | $82,080 | $23,611 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 82 | $11,070 | $3,955 | 35.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $5,775 | $2,814 | 48.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $16,775 | $2,513 | 15.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 29 | 30 | $3,300 | $2,076 | 62.9% |
| 90739 | Hepatitis b vaccine (hepb), cpg-adjuvanted, adult dosage, 2 dose or 4 dose schedule, for intramuscular use | Office | 2023 | 11 | 12 | $2,820 | $1,712 | 60.7% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 14 | 14 | $4,046 | $1,670 | 41.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 16 | $7,440 | $1,461 | 19.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 36 | $1,368 | $972.40 | 71.1% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 23 | 25 | $2,250 | $953.00 | 42.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 24 | 24 | $2,640 | $796.26 | 30.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 41 | 82 | $1,886 | $735.49 | 39.0% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2023 | 26 | 52 | $1,820 | $692.25 | 38.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 14 | 14 | $1,260 | $495.56 | 39.3% |
| G0010 | Administration of hepatitis b vaccine | Office | 2023 | 11 | 12 | $456.00 | $314.60 | 69.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $418.00 | $286.00 | 68.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 25 | $1,025 | $215.80 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 226 | 487 | $86,347 | $21,080 | 24.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $9,355 | $5,019 | 53.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 58 | 58 | $6,380 | $3,975 | 62.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 68 | $8,636 | $2,825 | 32.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 29 | 32 | $14,475 | $2,167 | 15.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 68 | 68 | $2,584 | $1,833 | 70.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 117 | 117 | $31,653 | $1,662 | 5.3% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 35 | 35 | $3,150 | $1,247 | 39.6% |
About Dr. Philip Hartman, M.D
Dr. Philip Hartman, M.D is a Family Medicine healthcare provider based in Taylor Mill, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2012. The National Provider Identifier (NPI) number assigned to this provider is 1548524457.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Hartman, M.D has received a total of $6,418 in payments from pharmaceutical and medical device companies, with $467.82 received in 2024. These payments were reported across 419 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,365).
As a Medicare-enrolled provider, Hartman has provided services to 2,772 Medicare beneficiaries, totaling 4,080 services with total Medicare billing of $209,509. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Taylor Mill, KY
- Active Since 06/26/2012
- Last Updated 08/22/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1548524457
Products in Payments
- FARXIGA (Drug) $763.60
- VRAYLAR (Drug) $742.79
- Ozempic (Drug) $330.79
- JARDIANCE (Drug) $255.37
- Aimovig (Biological) $196.05
- ENTRESTO (Drug) $193.64
- CHANTIX (Drug) $188.13
- SYMBICORT (Drug) $160.25
- MYRBETRIQ (Drug) $159.66
- XARELTO (Drug) $145.88
- STIOLTO (Drug) $139.76
- UBRELVY (Drug) $138.36
- TROKENDI XR (Drug) $124.60
- LYRICA (Drug) $116.37
- EVENITY (Biological) $115.75
- TRELEGY ELLIPTA (Drug) $111.81
- Livalo (Drug) $105.89
- FREESTYLE LIBRE 2 (Device) $104.39
- FASENRA (Drug) $102.43
- Rybelsus (Drug) $102.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Taylor Mill
Laura Foor, D.o, D.O
Family Medicine — Payments: $8,415
Family Medicine $8,415
Dr. Simon Lovasco, M.d, M.D
Family Medicine — Payments: $7,970
Family Medicine $7,970
Dr. Stephanie Stirrat, M.d, M.D
Family Medicine — Payments: $7,079
Family Medicine $7,079
Dr. Esther Saalfeld, Md, MD
Family Medicine — Payments: $5,870
Family Medicine $5,870
Kevin Feeley, Do, DO
Family Medicine — Payments: $1,147
Family Medicine $1,147
Alissa Lenz-Laporta, Do, DO
Family Medicine — Payments: $243.23
Family Medicine $243.23